Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 1.42 is 100% below its 5-year average of 1403.80, near the low end of its 5-year range (0.00–13939.67).
As of the fiscal period ended Wednesday, December 31, 2025. 67.85% below its 12-month average of 4.40.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2025-12-31): 1.42.
CURRENT RATIO
1.42
CURRENT RATIO AVG TTM
4.40
CURRENT RATIO AVG 3Y
11.64
CURRENT RATIO AVG 5Y
1403.80
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-67.85%
CURRENT VS 3Y AVG
-87.85%
CURRENT VS 5Y AVG
-99.90%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.75
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
-62.27%
vs the sector median at left
Regencell Bioscience Holdings Limited
Market Cap
$3.82B
Current Ratio
1.42
TTM Avg
4.40
3Y Avg
11.64
5Y Avg
1403.80
Market Cap
$4.02B
Current Ratio
18.27
TTM Avg
19.28
3Y Avg
20.00
5Y Avg
29.44
Market Cap
$4.05B
Current Ratio
12.77
TTM Avg
10.57
3Y Avg
9.28
5Y Avg
8.78
Market Cap
$3.56B
Current Ratio
3.87
TTM Avg
5.22
3Y Avg
3.96
5Y Avg
4.18
Market Cap
$3.51B
Current Ratio
50.82
TTM Avg
11.65
3Y Avg
9.40
5Y Avg
9.07
Market Cap
$3.50B
Current Ratio
21.02
TTM Avg
15.64
3Y Avg
20.34
5Y Avg
22.11
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Regencell Bioscience Holdings Limited (RGC) | $3.82B | 1.42 | 4.40 | 11.64 | 1403.80 |
| ICU Medical, Inc. (ICUI)vs › | $3.97B | 2.43 | 2.47 | 2.49 | 3.30 |
| Relay Therapeutics, Inc. (RLAY)vs › | $4.02B | 18.27 | 19.28 | 20.00 | 29.44 |
| AbCellera Biologics Inc. (ABCL)vs › | $4.05B | 12.77 | 10.57 | 9.28 | 8.78 |
| Veracyte, Inc. (VCYT)vs › | $3.58B | 9.16 | 6.44 | 5.38 | 7.95 |
| LivaNova PLC (LIVN)vs › | $4.14B | 1.45 | 2.12 | 2.54 | 2.24 |
| iRhythm Technologies, Inc. (IRTC)vs › | $3.56B | 3.87 | 5.22 | 3.96 | 4.18 |
| Tango Therapeutics, Inc. (TNGX)vs › | $3.51B | 50.82 | 11.65 | 9.40 | 9.07 |
| Xenon Pharmaceuticals Inc. (XENE)vs › | $3.50B | 21.02 | 15.64 | 20.34 | 22.11 |
| Celcuity Inc. (CELC)vs › | $3.50B | 8.93 | 9.13 | 14.29 | 16.91 |
Current Ratio
1.42
Quick Ratio
1.42
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2025-12-31 | 1.42 |
| 2025-06-30 | 7.39 |
| 2024-12-29 | 0.00 |
| 2024-06-30 | 41.92 |
| 2023-12-30 | 0.00 |
| 2023-06-30 | 19.15 |
| 2022-12-30 | 0.00 |
| 2022-06-30 | 28.46 |
| 2021-12-30 | 13939.67 |
| 2021-06-30 | 0.02 |
| 2020-12-30 | 0.09 |
| 2020-06-30 | 0.12 |
| 2019-12-30 | 0.00 |
